print PRINT

SCIENCE > Health

GOJ to strengthen assistance for domestic firms developing COVID-19 vaccines

  • May 25, 2020
  • , Yomiuri, Nikkei
  • JMH Summary

Monday’s Yomiuri reported that Health Minister Kato said on an NHK program on Sunday that the GOJ will reinforce support for Japanese companies that are developing vaccines for COVID-19. The paper said related funding will be allocated in the FY2020 second supplementary budget. Kato reportedly said: “There is a global competition underway to develop vaccines. We will firmly support vaccine development in Japan.” He reportedly pointed out that it will be too late to set up production lines after the vaccine development is complete, and said the GOJ plans to assist companies in preparing their production systems in parallel with supporting the research and development of vaccines. The paper noted that the U.S. and China have already begun clinical trials of COVID-19 vaccines.

 

In a related development, today’s Nikkei wrote that an Osaka-based pharmaceutical venture plans to conduct clinical trials of its COVID-19 vaccine in July in the hope of obtaining the Health Ministry’s approval by the end of this year. The company reportedly plans to secure some 2 billion yen ($18.6 million) in subsides from a GOJ-affiliated research foundation.

  • Ambassador
  • Ukraine
  • OPINION POLLS
  • COVID-19
  • Trending Japan